Yuvaraj, Jeremy
Lim, Egynne
Vo, Tony
Huynh, David
Rocco, Cheniqua
Nerlekar, Nitesh
Cheng, Kevin
Lin, Andrew
Dey, Damini
Nicholls, Stephen J.
Kangaharan, Nadarajah
Wong, Dennis T.L.
Article History
Received: 8 January 2023
Accepted: 24 August 2023
First Online: 19 September 2023
Competing interests
: SJN has received grant funding from AstraZeneca, New Amsterdam Pharma, Amgen, Anthera, Eli Lilly, Esperion, Novartis, Cerenis, The Medicines Company, Resverlogix, InfraReDx, Roche, Sanofi-Regeneron, and Liposcience, and consulting fees from AstraZeneca, Amarin, Akcea, Eli Lilly, Anthera, Omthera, Merck, Takeda, Resverlogix, Sanofi-Regeneron, CSL Behring, Esperion, and Boehringer Ingelheim. DW has received speaker honoraria from AstraZeneca, Pfizer, and Eli-Lilly. All other authors have no conflicts of interest to disclose.